Cannabidiol as a Putative Novel Therapy for Diabetic Retinopathy: A Postulated Mechanism of Action as an Entry Point for Biomarker-Guided Clinical Development

Publisher： Bentham Science Publishers

E-ISSN： 1875-6913|7|3|215-222

ISSN： 1875-6921

Source： Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol.7, Iss.3, 2009-01, pp. : 215-222

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacologic therapy for diabetic retinopathy

By Speicher Matthew A   Danis Ronald P   Criswell Mark   Pratt Linda  

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 1, 2003-05 ,pp. : 239-250

Informa Healthcare

Access to resources Recommend Favorite

Anthocyanins as a Potential Therapy for Diabetic Retinopathy

By  

Current Medicinal Chemistry, Vol. 22, Iss. 1, 2014-11 ,pp. : 51-58

Bentham Science Publishers

Access to resources Recommend Favorite

Prasugrel: a novel platelet ADP P2Y12 receptor antagonist. A review on its mechanism of action and clinical development

By Angiolillo Dominick J   Suryadevara Siva   Capranzano Piera   Bass Theodore A  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 16, 2008-11 ,pp. : 2893-2900

Informa Healthcare

Access to resources Recommend Favorite

Anti-angiogenic therapy of proliferative diabetic retinopathy

By Danis R.P.   Ciulla T.A.   Criswell M.   Pratt L.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 3, 2001-03 ,pp. : 395-407

Informa Healthcare

Access to resources Recommend Favorite

Biomarker-Guided Strategy for Treatment of Autism Spectrum Disorder (ASD)

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 5, 2016-05 ,pp. : 602-613

Bentham Science Publishers

Access to resources Recommend Favorite